Abstract Submission Instructions

Submission Deadline: Oct. 20, 2016



PDF Download

All submitting authors must file disclosures before submitting your research on the ACC's Disclosure Website. Disclosures are only needed for yourself and the lead investigator. You will be asked to identify the lead investigator during the submission process. Abstracts will be considered “complete” without completed disclosures and will go to review as long as all other submission elements are complete. You do not need to take any action at this stage; ACC staff will contact coauthors separately to obtain these disclosures as a condition of submission. All disclosures need to be completed by December 19, 2016. Failure to provide disclosure information by the December 19, 2016 deadline will result in the removal of an accepted abstract from the program.

The ACC employs a “single sign-on” process, which will improve the efficiency of the submission process. Please do not create a new ACC account if you already have one. Only one account is allowed per user in order to offer you high-quality services. Contact the Resource Center at resource@acc.org or 800-253-4636, ext. 5603, if you are unsure whether you have an account.

Once you have signed in, the submitting author’s name and ID number will automatically prepopulate in the submission system; the name and ID number must match and are not editable. The submitting author’s name entered in the passgate system MUST be the author who will present the abstract/LBCT/case if selected. Notification of acceptance will be sent to this person.

There are ten major steps necessary to complete the ACC online submission system. Each step has tips to help you successfully complete each item. Please proofread and spellcheck your submission carefully.

Having technical difficulties with your submission? Click here for a possible solution.

  Entering Abstract Information
  Entering Abstract Information
  A. Title
  A. Title



  1. Do not bold, italicize, underline, superscript or subscript any items in the title.
  2. Do not include authors in the title. If you enter authors in the title, they will be removed.
  3. Do not include institutions in the title. If you enter institutions in the title, they will be removed.
  4. Do not use the “Enter” button in your title. This action will add hard returns, which are not allowed.
  5. Capitalize the first letter of all major words in the title as well as articles and conjunctions of four letters or more.
  6. It is not necessary to capitalize prepositions four letters or longer in headings.
  7. Do not use abbreviations in the title. Abbreviations may be used in the abstract body.
  8. Do not end the title with a period.
  9. If the title contains more than one statement, use only one space after a period or colon.
  10. Do not use a comma before “and” in a series.
  11. Use a comma for number 1,000 and above.
  12. Substitute a colon for a dash/hyphen except when using prefixes.
  13. Do not use quotation marks in a title.
  14. Hyphenate the first prefix word when there is more than one prefix word used such as Non-Anti...
  15. For more information about title guidelines see the Style and Editing Guidelines at the end of this document.
  B. Abstract Categories
  B. Abstract Categories

Submit an abstract to one of the following categories, based on the area of research:

  1. Acute and Stable Ischemic Heart Disease: Basic
  2. Acute and Stable Ischemic Heart Disease: Clinical
  3. Acute and Stable Ischemic Heart Disease: Therapy
  4. Arrhythmias and Clinical EP: Basic
  5. Arrhythmias and Clinical EP: Devices
  6. Arrhythmias and Clinical EP: Other
  7. Arrhythmias and Clinical EP: Sports and Exercise
  8. Arrhythmias and Clinical EP: Supraventricular/Ventricular Arrhythmias
  9. Congenital Heart Disease: Adult
  10. Congenital Heart Disease: Pediatric
  11. Congenital Heart Disease: Therapy
  12. Heart Failure and Cardiomyopathies: Basic
  13. Heart Failure and Cardiomyopathies: Clinical
  14. Heart Failure and Cardiomyopathies: Therapy
  15. Interventional Cardiology: ACS/AMI/Hemodynamics and Pharmacology
  16. Interventional Cardiology: Angiography and Interventional CT/MR
  17. Interventional Cardiology: Aortic Valve Disease
  18. Interventional Cardiology: Carotid and Endovascular Intervention
  19. Interventional Cardiology: Complex Patients/Comorbidities
  20. Interventional Cardiology: Coronary Intervention: CTO
  21. Interventional Cardiology: Coronary Intervention: Devices
  22. Interventional Cardiology: Coronary Intervention: Left Main, Multivessel, Bifurcation
  23. Interventional Cardiology: IVUS and Intravascular Physiology
  24. Interventional Cardiology: Mitral and Structural Heart Disease
  25. Interventional Cardiology: Translation and Pre-clinical Research
  26. Interventional Cardiology: Vascular Access and Complications
  27. Non Invasive Imaging: CT/Multimodality, Angiography, and Non-CT Angiography
  28. Non Invasive Imaging: Echo
  29. Non Invasive Imaging: MR
  30. Non Invasive Imaging: Nuclear
  31. Non Invasive Imaging: Sports and Exercise
  32. Prevention: Clinical
  33. Prevention: Hypertension
  34. Prevention: Rehabilitation
  35. Pulmonary Hypertension and Pulmonary Thrombo-embolic Disease
  36. Valvular Heart Disease: Clinical
  37. Valvular Heart Disease: Therapy
  38. Vascular Medicine: Basic
  39. Vascular Medicine: Endovascular Therapy
  40. Vascular Medicine: Non Coronary Arterial Disease
  41. Vascular Medicine: Venous Disease
  42. Spotlight on Special Topics: Education, Innovation, Advocacy, Social Media, Leadership and Practice Management

AGAIN THIS YEAR: Abstracts with a Sports and Exercise focus may be submitted into one of two categories:

7. Arrhythmias and Clinical EP: Sports and Exercise

31. Non Invasive Imaging: Sports and Exercise Abstracts submitted to a category that do not match the subject matter of the abstract may be given a low score from reviewers.

  C. Keywords
  C. Keywords



  1. Select up to four keywords.
  2. Only two keywords are required.
  3. Leave unused/unneeded keyword fields blank.
  4. Do not enter the same keyword more than once.
  D. Institutions and Authors (Responsible Institutions)
  D. Institutions and Authors (Responsible Institutions)



  1. List the complete name including a full first name and initials. Multiple word first names should be placed in the “First Name” field.
  2. Please use English characters when entering names and eliminate any non-English characters such as tildes and umlauts.
  3. Do not include title, degrees, or suffix in the “Last Name” field.
  4. Do not enter more than one author in each “First Name” or “Last Name” field. If this is done, you will be contacted to correct this entry.
  5. If more than one abstract is submitted, please spell authors in exactly the same manner. This is important when indexing all authors in the online/mobile program planner systems.
  6. Use the author group field only for the name of an investigating team. This is typically something like “Investigators for ACC.” Do not use the author group to list individual authors. If this is done, you will be contacted to correct this entry. Authors entered as an “Author Group” will not be listed in the author index of the onsite programs.
  7. The author order is the order that authors will be listed in publications if the abstract is selected for presentation.
  8. The contact information is not used as part of the institutions listed in any abstract publication. Institutions are entered in a separate area.
  9. The submitting author will be notified about the outcome of the review and selection process.
  E. Abstract (Important Issues)
  E. Abstract (Important Issues)



  1. Abstracts MUST conform to specific size limits or they will remain in an incomplete status and will not be reviewed. Your abstract may not contain more than 1,900 characters, not including spaces. A graphic, or a table created with the table generator, equals 600 characters and is included as part of the 1,900 character limit.
  2. Use the standard Times New Roman font for text and Symbol font for symbols (DO NOT USE A THIRD-PARTY SYMBOL FONT!); any other fonts will not be accepted. Set all text as flush left, unjustified, and wrapping text as you type. Do NOT place hard returns at the end of each line.
Abstract Body/Text
  1. You may type the body of the abstract directly into the space provided for the abstract body or upload this information. Do not embed graphics or images in a file you intend to upload. They must be uploaded separately.
  2. You may include a table in the body of the abstract by uploading a word processing document that has a table in it. This cannot be a table linked to a spreadsheet.
  3. You may use five unique abbreviations in the body of the abstract. Spell out the complete phrase followed by the abbreviation in parentheses the first time the abbreviation is used. Abbreviations are not allowed in the title of the abstract.
  4. Do not include the title in the abstract body. The title will be collected in the Title Section.
  5. Do not include authors and institutions in the abstract body. This data will be collected in the Author Section.
  6. The abstract must be presented in the following sequence, using the headings listed: (These headings have been setup in the abstract body text for you.)



    Background: In an initial paragraph, provide relevant information regarding the background and purpose of the study, preferably in no more than one or two sentences.



    Methods: Briefly state the methods used.



    Results: Summarize the results in sufficient detail to support the conclusions.



    Conclusion: State the conclusions reached. It is not satisfactory to state “the results will be discussed.” Please proofread carefully for factual, spelling, and size errors. If published, the abstract will appear exactly as the online system confirmation shows.
Clinical Implications
  1. In a couple sentences, state the main clinical implications (or significance) of your study.
  2. This information may be used as discussion points in educational activities at ACC.17.
Tables
  1. You may include a table in a file that you upload or create it online using the table generator.
  2. It is recommended you create the table in your word processor then use the file upload feature to transfer the document to the abstract site. Table generation in a word processor is much easier to accomplish than using the table generator.
  3. Do not embed a spreadsheet within your document. Even though it appears as a table, you will not be able to upload the file. You may copy the table from a spreadsheet and then paste it into the word processor as a table instead of a linked spreadsheet.
  4. A table equals 600 characters and is included as part of the 1,900 character limit.
Graphics
  1. Graphics should be high resolution and have a file type of “gif”, “jpg”, or “jpeg”. Even though the abstract system may allow you to upload a graphic with a different file type those graphics will not be reviewed or reproduced if the abstract is selected.
  2. Do not submit tables as graphics.
  3. Do not embed graphics or images in a file you intend to upload. Use the separate graphic upload feature if you wish to include a graphic/image.
  4. Please keep in mind that large and/or complex graphics may not be readable in print or electronic formats.
  5. There should be no “white space” or border around the graphic.
  6. A graphic equals 600 characters and is included as part of the 1,900 character limit.
 
  When Is a Submission Considered Complete?
  When Is a Submission Considered Complete?
Submission is complete and ready for submission when, in the “Review My Work” section, you see the words “This submission is complete.” It is only submitted to reviewers after the deadline date. You may update or make changes to your abstract up until Tuesday, October 18, 2016, 11:59 p.m., ET. The date your submission was last edited may be found in the Review My Work Section next to the words “Current Date/Time”. This will change each time there has been an alteration.
 
  Revisions
  Revisions
Revisions to your submission can be made until the date listed above. No changes will be accepted after this date. This includes adding authors to your author block. If any changes are made prior to the deadline, you must select “Review My Work” from the menu on the left. Make certain that you see the words “This submission is complete.”
 
  Changing Presenting Authors
  Changing Presenting Authors
If your abstract is selected for presentation, you may change the presenting author to any author listed on your abstract. You may not change the presenting author to someone who is not listed on your submission and you may not add authors after the submission deadline. Presenting author changes can be made up until ACC.17. However, if you would like these changes to be reflected in the published version of your abstract, you must notify Robin Young (ryoung@acc.org) by no later than Friday, January 20, 2017.
 
  Disposition/Notification of Acceptance
  Disposition/Notification of Acceptance
You will be sent a notification with the status of your submission via email the week of December 19, 2016, and directed to a website to supply additional information. NEW THIS YEAR: Authors can check the status of their submissions by visiting the ACC.17 site and logging into their accounts. Presenters can also check the disclosure status of the lead investigator using the same link.
 
  Withdrawals
  Withdrawals
In order for an accepted abstract to be withdrawn and not appear in publications, notification must be received by Friday, January 20, 2017.



To withdraw a submitted ACC abstract, Challenging Case, Cardiovascular Team Case, or FIT Clinical Decision-Making Case, written notification must be sent to ryoung@acc.org.



To withdraw an LBCT, written notification must be sent to hhopper@acc.org. To withdraw a submitted YIA abstract, written notification must be sent to kroberts@acc.org.



This notification must include the title, authors and affiliations (as submitted), the control number, and the name, affiliation, phone, fax and e-mail of the submitter. We recommend using the summary page as part of this notification.
 
  Fee Schedule for Presenters
  Fee Schedule for Presenters
  1. There is a $35 (USD) nonrefundable processing fee for each abstract, Cardiovascular Team Case, FIT Clinical Decision-Making Case, or Challenging Case submitted payable online by credit card only. Late-breaking clinical trial submitters must pay a $250 (USD) nonrefundable fee.
  2. If a person is both an abstract presenter and an invited speaker, the registration fee is waived.
  3. If a person is a Late-breaking clinical trial presenter, the registration fee is waived.
 
  Logging onto the ACC Submission System
  Logging onto the ACC Submission System

Because you have read the ACC.17 Submission Instructions for using the web-based ACC abstract system, you are now ready to enter your submission. Begin your submission now.

Please save this page as a favorite in your Web browser so that you can quickly return to the submission system.

 
  Style and Editing Guidelines
  Style and Editing Guidelines
Always CAP

After

Are

Be

Do

Is

Not

They

We

Who

Do not CAP

(unless at the beginning of a title or after a colon)

a

an

and

as

at

but

by

de (French)

for

in

of

on

or

the

to

via

von (German)

One Word Includes

...arrhythmia

...year

Anti...

Multicenter...

Multiplane...

Non...

Over...

Post...

Pre...

Sub...

Two Words

Contrast Enhanced

Double Blind

Dual Chamber

High...

In...

Low...

Q Wave

Multi Vessel

Single Vessel

T Wave

Hyphenated Words

-Based

-D

-Dependent

-Derived

-Dimensional

-Free

-Induced

-Like

-Medicated

-Powered

-Sided

-Term

Cardioverter-Defibrillator

Cost-Effective

End-Stage

Follow-Up

High-Risk

His-Bundle

In-Hospital

In-Patient

Low-Risk

No-Flow

No-Reflow

On-Line

Real-Time

Signal-Averaged

Three-Dimensional

Ten-Year

Advertisement

ACC Logo
ACC.17 on Social Media:
      
2017 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us